During the past decade, Centro de Pesquisa Sao Lucas conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro de Pesquisa Sao Lucas" are "Obesity" (3 trials), "Heart Failure With Preserved Ejection Fraction" (2 trials), "Overweight" (2 trials), "Corona Virus Infection" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Centro de Pesquisa Sao Lucas" in a lesser frequency.

Most popular intervention types in "Centro de Pesquisa Sao Lucas" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Tirzepatide" (3 trials), "Baricitinib" (1 trials), "Insulin Degludec" (1 trials) and "Insulin Efsitora Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Pesquisa Sao Lucas" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Pesquisa Sao Lucas". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro de Pesquisa Sao Lucas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Pesquisa Sao Lucas, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".